Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | endothelin receptor type B | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.013 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0076 | 0.2852 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0127 | 0.9706 | 0.9706 |
Schistosoma mansoni | 6-phosphofructokinase | 0.013 | 1 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0076 | 0.2852 | 0.5 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0076 | 0.2852 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.013 | 1 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0127 | 0.9706 | 0.9706 |
Onchocerca volvulus | 0.013 | 1 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.013 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0127 | 0.9706 | 0.9706 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.013 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0127 | 0.9706 | 0.9604 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.013 | 1 | 1 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0127 | 0.9706 | 0.9706 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.013 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0076 | 0.2852 | 0.5 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0076 | 0.2852 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.011 nM | Inhibitory activity against [125I]-ET-1 binding to human endothelin A receptor | ChEMBL. | 15006391 |
IC50 (binding) | = 0.011 nM | Inhibitory activity against [125I]-ET-1 binding to human endothelin A receptor | ChEMBL. | 15006391 |
IC50 (binding) | = 0.048 nM | Inhibitory activity against [125I]-ET-1 binding to human endothelin A receptor | ChEMBL. | 15006391 |
IC50 (binding) | = 0.048 nM | Inhibitory activity against [125I]-ET-1 binding to human endothelin A receptor | ChEMBL. | 15006391 |
IC50 (binding) | = 5.6 nM | Inhibitory activity against [125I]-ET-1 binding to human endothelin B receptor | ChEMBL. | 15006391 |
IC50 (binding) | = 5.6 nM | Inhibitory activity against [125I]-ET-1 binding to human endothelin B receptor | ChEMBL. | 15006391 |
IC50 (binding) | = 6 nM | Inhibitory activity against [125I]-ET-1 binding to human endothelin B receptor | ChEMBL. | 15006391 |
IC50 (binding) | = 6 nM | Inhibitory activity against [125I]-ET-1 binding to human endothelin B receptor | ChEMBL. | 15006391 |
Selectivity ratio (binding) | = 120 | Selectivity ratio of inhibitory activity towards endothelin receptor A to endothelin receptor B (ETB/ETA) | ChEMBL. | 15006391 |
Selectivity ratio (binding) | = 550 | Selectivity ratio of inhibitory activity towards endothelin receptor A to endothelin receptor B (ETB/ETA) | ChEMBL. | 15006391 |
Selectivity ratio (binding) | = 120 | Selectivity ratio of inhibitory activity towards endothelin receptor A to endothelin receptor B (ETB/ETA) | ChEMBL. | 15006391 |
Selectivity ratio (binding) | = 550 | Selectivity ratio of inhibitory activity towards endothelin receptor A to endothelin receptor B (ETB/ETA) | ChEMBL. | 15006391 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.